The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with β-interferon 1a (Avonex)

被引:0
作者
Davydovskaya M.V. [1 ]
Boiko A.N. [1 ]
Podoprigora A.E. [2 ]
Pronin I.N. [2 ]
Kornienko V.N. [2 ]
Gusev E.I. [1 ]
机构
[1] N. I. Pirogov Russian National Medical Research University, Moscow
[2] Department of Radiological and Surgical Methods for Diagnosis and Treatment, Academician N. N. Burdenko Research Institute of Neurosurgery, Russian Academy of Medical Sciences, Moscow
关键词
interferon β-1a for intramuscular use; multiple sclerosis; neurodegenerative process; proton magnetic resonance spectroscopy;
D O I
10.1007/s11055-013-9827-8
中图分类号
学科分类号
摘要
The dynamics of changes in the N-acetylaspartate/creatine ratio (NAA/Cr) in brain tissue in patients with multiple sclerosis (MS) were studied by proton multivoxel magnetic resonance spectroscopy (PMRS) to identify relationships between these parameters and the clinical status of patients to assess the potential for using this method in monitoring disease severity and the extent of the neurodegenerative process. The potential neuroprotective effect of treatment with an interferon β-1a formulation for intramuscular administration (IFNβ-1a, Avonex) in patients with remitting MS (rMS) was also studied. A total of 26 patients with rMS took part in the study. Investigations included history-taking, neurological examination with assessment on the EDSS, neuropsychological testing, and dynamic MRI studies using PMRS. A decrease in the NAA/Cr ratio was seen in patients with rMS as compared with healthy subjects. Analysis of the NAA/Cr ratio at one year demonstrated a significant reduction. A negative relationship was found between the NAA/Cr ratio in brain tissue and the levels of neurological and cognitive deficit. Analysis of intramuscular IFNβ-1a treatment of MS demonstrated a stabilizing neuroprotective effect through the one-year treatment period, which may be associated with the effects of this agent on the neurodegenerative process in MS. © 2013 Springer Science+Business Media New York.
引用
收藏
页码:907 / 912
页数:5
相关论文
共 31 条
  • [21] Lassmann H., Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease, J. Neural Transm., 118, pp. 747-752, (2011)
  • [22] Mesaros S., Rocca M.A., Riccitelli G., Et al., Corpus callosum damage and cognitive dysfunction in benign multiple sclerosis, Human Brain Mapping, 30, pp. 2656-2666, (2009)
  • [23] Moffett J.R., Namboodiri M.A.A., Cangro C.B., Neale J.H., Immunohistochemical localization on N-acetylaspartate in rat brain, Neuroreport, 2, pp. 131-134, (1991)
  • [24] Narayana P.A., Wolinsky J.S., Rao S.B., Et al., Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis, Mult. Scler., 10, pp. 73-78, (2004)
  • [25] Rimkus C.M., Jungueira T.F., Lyra K., Et al., Corpus callosum microstructural changes correlate with cognitive dysfunction of early stages of relapsing-remitting multiple sclerosis: Axial and radial diffusivities, Mult. Scler. Int., pp. 7-15, (2011)
  • [26] Sajja B.R., Narayana P.A., Wolinsky J.S., Et al., Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: Multicentre study, Mult. Scler., 14, pp. 73-80, (2008)
  • [27] Sajja B.R., Wolinsky J.S., Narayanna P.A., Proton magnetic resonance spectroscopy in multiple sclerosis, Neuroimaging Clin. N. Am., 19, pp. 45-58, (2009)
  • [28] Sijens P.E., Mostert J.P., Oudkerk M., Et al., (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: Initial findings, Eur. Radiol., 16, 2, pp. 489-495, (2006)
  • [29] Simmons M.L., Frondoza C.G., Coyle J.T., Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies, Neurosci., 45, pp. 37-45, (1991)
  • [30] Stadelmann C., Albert M., Wegner C., Et al., Curr. Opin. Neurol., 21, pp. 229-234, (2008)